342 participants
A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-29
- Start Date:
- 2021-03-12
- Completion:
- 2029-02-01
Conditions
- Hepatocellular Carcinoma
Interventions
- DRUG
- DEVICE
No Results Yet